missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Influenza A H1N1 HA (A/Puerto Rico/8/34) Recombinant Rabbit Monoclonal Antibody (016)
GREENER_CHOICE

Rabbit Recombinant Monoclonal Antibody

£132.00 - £357.00

Specifications

Antigen Influenza A H1N1 HA (A/Puerto Rico/8/34)
Clone 016
Concentration 1 mg/mL
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Applications ELISA
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30533935
GREENER_CHOICE
View Documents
Invitrogen™
MA560326
100 μL
£357.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30535902
View Documents
Invitrogen™
MA560327
20 μL
£132.00
20µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Recognizes Influenza H1N1 (A/Puerto Rico/8/1934) Hemagglutinin/HA; No cross-reactivity in ELISA with: H1N1 (A/Victoria/4897/2022) HA Protein; H1N1 (A/Wisconsin/588/2019)/(A/Victoria/2570/2019) HA Protein; H1N1 (A/Wisconsin/67/2022) HA Protein; H3N2 (A/Darwin/6/2021) HA Protein; H3N2 (A/Darwin/9/2021) HA Protein; Influenza B (B/Austria/1359417/2021) HA Protein; Influenza B (B/PHUKET/3073/2013) HA Protein; Influenza B (B/Washington/02/2019) HA Protein.

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.
Specifications

Specifications

Influenza A H1N1 HA (A/Puerto Rico/8/34)
1 mg/mL
ELISA
Unconjugated
Rabbit
RUO
PBS with no preservative
Recombinant Influenza H1N1 (A/Puerto Rico/8/1934) Hemagglutinin/HA protein (Met1-Gln528).
Antibody
016
-20°C, Avoid Freeze/Thaw Cycles
Recombinant Monoclonal
Liquid
IgG
Virus
flu hemagglutinin; H1N1 HA; H1N1 hemagglutinin; Influenza H1N1; influenza hemagglutinin
Primary
Protein A
Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Product Certifications
Berichtigung von Produktinhalten

Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.

Name des Produkts

Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.

Vielen Dank, dass Sie uns helfen, unsere Website zu verbessern. Ihr Feedback wurde übermittelt